Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 14 studies | 32% ± 9% | |
| B cell | 8 studies | 19% ± 3% | |
| glutamatergic neuron | 7 studies | 48% ± 24% | |
| naive B cell | 5 studies | 19% ± 2% | |
| GABAergic neuron | 5 studies | 50% ± 21% | |
| T cell | 4 studies | 21% ± 4% | |
| endothelial cell | 3 studies | 27% ± 7% | |
| plasma cell | 3 studies | 21% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 25% ± 8% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 4% | |
| memory B cell | 3 studies | 21% ± 5% | |
| natural killer cell | 3 studies | 30% ± 7% | |
| lymphocyte | 3 studies | 34% ± 12% | |
| granule cell | 3 studies | 22% ± 3% | |
| astrocyte | 3 studies | 22% ± 4% | |
| interneuron | 3 studies | 48% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 40% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 94% | 981.00 | 230 / 245 | 91% | 10.23 | 455 / 502 |
| breast | 82% | 610.28 | 378 / 459 | 87% | 19.92 | 971 / 1118 |
| lung | 97% | 407.63 | 559 / 578 | 67% | 4.43 | 779 / 1155 |
| brain | 81% | 1081.36 | 2128 / 2642 | 71% | 5.42 | 498 / 705 |
| stomach | 75% | 314.70 | 268 / 359 | 70% | 4.38 | 200 / 286 |
| intestine | 60% | 699.41 | 576 / 966 | 80% | 5.85 | 424 / 527 |
| bladder | 62% | 590.24 | 13 / 21 | 71% | 5.34 | 359 / 504 |
| pancreas | 28% | 58.20 | 91 / 328 | 76% | 4.85 | 135 / 178 |
| spleen | 100% | 1866.11 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 92% | 1662.42 | 855 / 929 | 0% | 0 | 0 / 0 |
| adrenal gland | 28% | 96.03 | 72 / 258 | 63% | 7.94 | 144 / 230 |
| esophagus | 35% | 126.59 | 505 / 1445 | 51% | 3.09 | 93 / 183 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 7.71 | 24 / 29 |
| uterus | 26% | 58.76 | 44 / 170 | 53% | 3.69 | 245 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 3.11 | 30 / 45 |
| adipose | 65% | 170.15 | 781 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 44% | 109.29 | 39 / 89 | 20% | 0.62 | 179 / 901 |
| skin | 27% | 58.16 | 490 / 1809 | 23% | 1.21 | 109 / 472 |
| thymus | 21% | 76.32 | 134 / 653 | 22% | 1.46 | 132 / 605 |
| ovary | 4% | 7.70 | 7 / 180 | 13% | 0.50 | 54 / 430 |
| blood vessel | 13% | 34.78 | 178 / 1335 | 0% | 0 | 0 / 0 |
| liver | 3% | 5.19 | 7 / 226 | 5% | 0.25 | 21 / 406 |
| heart | 4% | 7.10 | 33 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0.42 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050658 | Biological process | RNA transport |
| GO_0005764 | Cellular component | lysosome |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0015485 | Molecular function | cholesterol binding |
| GO_0051033 | Molecular function | RNA transmembrane transporter activity |
| GO_0003725 | Molecular function | double-stranded RNA binding |
| Gene name | SIDT1 |
| Protein name | SID1 transmembrane family member 1 |
| Synonyms | |
| Description | FUNCTION: In vitro binds long double-stranded RNA (dsRNA) (500 and 700 base pairs), but not dsRNA shorter than 300 bp. Not involved in RNA autophagy, a process in which RNA is directly imported into lysosomes in an ATP-dependent manner, and degraded. . |
| Accessions | ENST00000264852.9 [Q9NXL6-1] ENST00000393830.4 [Q9NXL6-2] Q9NXL6 |